The biotech has entered into a licensing and collaboration agreement with Swedish company AlzeCure Pharma for rights to the latter’s Alzheimer’s platform NeuroRestore, including the leading drug candidate ACD856. QuantumCell is paying only $12m upfront, but a tail-heavy weighting to the deal with milestone payments means the total transaction could exceed $2.2bn.
Under a new five-year agreement, Haleon plans wider adoption of AI-powered tools to help employees “automate routine tasks, collaborate more effectively and focus on higher-value work,” the London-based company said in a July 1 announcement days after Microsoft revealed the deal. The Advil maker already used Microsoft 365 Copilot before the latest relationship upgrade.
With over 25 years of experience in the international CDMO and biotechnology industries, Torsten Woehr combines strong leadership skills in the commercial sector with in-depth knowledge of operational business. Most recently, he served as Chief Commercial Officer of Bachem, where he led global business operations and drove key strategic investments.
IMCD Group, a global partner for the distribution and formulation of speciality chemicals and ingredients, has opened its new Pharmaceutical Technical Centre and Food & Nutrition US Technical Hub in IMCD’s new offices in Allendale, New Jersey, USA. The new facilities are part of IMCD’s network of more than 80 technical centres globally.
Merck KGaA has agreed to acquire Bio-Techne for approximately $11.3 billion, in a deal designed to position the buyer as more of a leader across the life science value chain by expanding and combining its presence in high-growth, next-generation life-sci markets with Bio-Techne’s tools, analytical technologies, and consumables.
